Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Demographics of AOSD patients

From: Effects of HLA-DRB1 alleles on susceptibility and clinical manifestations in Japanese patients with adult onset Still’s disease

Variable Value
Number 87
Female, n (%) 69 (79.3)
Age at onset (years) 49.3 ± 19.9
Ferritin (ng/mL) 11251.2 ± 16997.9
CRP (mg/dL) 12.4 ± 8.2
ESR (mm(1 h)) 71.1 ± 30.1
Liver dysfunction, n (%) 68 (78.1)
MAS, n (%) 23 (26.4)
Initial dose of PSL (mg/day) 41.8 ± 12.2
Steroid pulse, n (%) 55 (63.2)
Immunosuppressant, n (%) 51 (58.6)
Biologics, n (%) 26 (29.8)
Polycyclic systemic type, n (%) 56 (64.3)
Monocyclic systemic type, n (%) 19 (21.8)
Chronic arthritis type, n (%) 12 (13.7)
Relapse, n (%) 40 (45.9)
  1. Mean ± standard deviation or number (percentage) is shown
  2. AOSD adult onset Still’s disease, CRP C-reactive protein, ESR erythrocyte sedimentation rate, MAS macrophage activation syndrome, PSL prednisolone